Allied Market Research


Digital Genome Market

Digital Genome Market Size, Share, Competitive Landscape and Trend Analysis Report by Product Type, by Applications and by End users : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Pharmaceuticals

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

A genome refers an organism’s complete set of DNA, comprising all of its genes and it possess entire set of information required to build and maintain organisms. While a digital genome refers to complete digital sets of genetic material that is present in DNA of an organism. It is utilized in the research on genetic disorders and chronic diseases. It offers instant access to trait sequences to understand issues regarding genetics of the diseases. Digital genomics has revolutionized innovation-centered research to derive valuable insights and understand complex genetic mechanisms.


Genomics is a traditional concept with traces of genome market traced back right from 1926 when a geneticist at the Jackson Laboratory Tom Roderick, coined the term genomics. In 1981, the 1st complete genome sequence of the human mitochondrion (16.6 kb), was registered. Then in 2003 the accomplishment of the Human Genome Project, sequencing of 3.2 billion base pairs of a DNA that make up the human genome, which took many years and cost hefty amounts of time and capital was completely sequenced, with every single human gene sequences were accessible in the public domain. 

COVID – 19 scenario analysis:  

  • The COVID-19 pandemic has emerged as a humanitarian as well as economic crisis, creating strain on the society and affecting millions of people and businesses
  • Industry closures and people are asked to stay in their homes which has cause taken a huge toll in terms of money and economic growth
  • Over 4 million people affected globally, with 300 thousand losing their lives due to SARS-CoV-2
  • Healthcare organizations are already working in battle mode, preparing new plans to respond growing COVID-19 patients, right from sourcing rapid diagnosing kits to sufficient PPE kits for workers
  • Due to diversion of medical field towards treating COVID-19, the funding to R&D activities related to digital genome has been reduced and this segment have to face negligence subsequently causing negative impact on digital genome market

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

Majority of intractable health challenges, especially cancer can be considered genomic as a disease. With digitization of the genome, healthcare professionals would be able to make a better decision regarding cancer treatment by understanding tumor’s genetic make-up. Digital genome would also aid in precision and customized medicine and development of highly targeted therapies with the potential to be applied across many diseases. These factors would fuel the market growth. The digital genome market is further driven by factors including increment in constantly evolving diseases patterns, high demand for precision medicine and treatment of disorders and diseases utilizing advanced technology fueled by digital genomics and heavy funding to research and development activities in genomics. Subsidizes and friendly policies provided by government and regulatory authorities and encouragement in usage of digital genomics are significant for the growth of digital genomics market.

On the contrary, high capital expenditure required to acquire and utilize digital genomics in research and treatment, lack of awareness and dearth of qualified, skilled staff to handle digitized advanced genomics and poorly developed healthcare infrastructure in developing economies are constrains foreseen to cause hindrances in the digital genome market growth. In addition, digital genome data privacy concerns, challenges regarding personal genomic profiling with regard to understanding of the risk of genetic disease have been deterrents restricting the market growth.  

However, the untapped markets in the Asia Pacific region are evaluated to develop at a significant rate due to rise in geriatric populace, developing infrastructure and insurance administrations would create profitable ventures for digital genome market.

Technological advancements to boost the market growth

Recent technological advancements and growing awareness regarding advantages in use of genomes for detection and treatment of diseases, primarily cancer is expected to drive growth of the digital genome market. For instance, the National Human Genome Research Institute (NHGRI) launched a strategic planning in February 2018, which will establish a plan of action for genomics research focusing on acceleration of breakthroughs and innovations in biomedical field. 

Integration of Artificial Intelligence and machine learning in current healthcare mechanisms are used to resolve issues such as identification of splice sites, promoters, enhancers, and positioned nucleosomes, annotating genomic sequence elements usually faced by genomics. For example, Congenica introduced a clinical genomics analysis platform Sapientia that uses algorithms to annotate and priorities variants from whole-exome sequencing to assist in the diagnosis of rare diseases by understanding their genetic makeup.

In December 2017, Google launched an Artificial Intelligence (AI) tool called DeepVariant, which uses AI to create precise model of an individual genome using sequencing data. From sequencing data, it is capable of automatically identifying mutations in small insertion and deletion, and single base-pair. 

Recently, the Canadian Genomics Cloud launched a public cloud platform that allows researchers from Canada to collect, store, share, and analyze genomics data for further discoveries ensuring privacy and security.  

Rising demand for personalized medications to fuel the growth

As per statistics and research by WHO, cancer is one of the prime causes of morbidity and mortality worldwide, accounting for almost 14 million cases in 2012. WHO also stats that 30-50% of deaths caused due to cancer can be reduced by appropriate treatment in early stages after diagnosis. Personalized medicine offers prominent techniques to fight diseases. Furthermore, rising incidences in diseases like AHDH, cancer require specialised and personalized treatment therapies owing to the nature of disease. With digitization of the genome, healthcare professionals would be able to make a better decision regarding cancer treatment by understanding tumor’s genetic make-up. These factors are promising the development of digital genomics market in near future.

Key benefits of the report:

  • This study presents the analytical depiction of the global digital genome industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global digital genome market share.
  • The current market is quantitatively analysed to highlight the digital genome treatment market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global digital genome market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Digital genome market research report:

  • What are the leading market players active in the digital genome market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?

Digital Genome Market Report Highlights

Aspects Details
By Product Type
  • Sequencing & analyzer instruments
  • DNA/RNA analysis kits
  • Sequencing & analysis software
  • Sample preparation instruments
By Applications
  • Microbiology
  • Reproductive & Genetic
  • Transplantation and Agriculture
  • Forensics
  • Research and Development
By End users
  • Academic Research Institutes
  • Diagnostics & Forensic Labs
  • Hospitals
  • Bio-pharmaceutical Companies
By Region
  • North America  (US, Canada, Mexico)
  • Europe  (France, Germany, UK, Italy, Spain, rest of Europe)
  • Asia-Pacific  (Japan, China, India, Australia, South Korea, rest of Asia-Pacific)
  • LAMEA  (Brazil, South Arabia, South Africa, rest of LAMEA)
Key Market Players

Becton Dickinson and Company, Qiagen and Thermo Fisher Scientific., Pacific Bioscience, Agilent Technologies Inc., Illumina, Genomic Health Inc., PerkinElmer Inc., Quest Diagnostics Inc., bioMerieux, GenMark Diagnostics Inc.

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Digital Genome Market

Global Opportunity Analysis and Industry Forecast, 2023-2032